Financhill
Back

Qiagen NV Quote, Financials, Valuation and Earnings

Qiagen NV Price Quote

$45.60
+0.01 (+-0.18%)
(Updated: September 20, 2024 at 6:58 AM ET)

Qiagen NV Key Stats

Sell
43
Qiagen NV (QGEN) is a Sell

Day range:
$45.53 - $46.06
52-week range:
$35.81 - $47.44
Dividend yield:
0%
P/E ratio:
29.88
P/S ratio:
5.26
P/B ratio:
2.98%

Volume:
1M
Avg. volume:
1.3M
1-year change:
10.25%
Market cap:
$10.1B
Revenue:
$2B
EPS:
$0.32

How Much Does Qiagen NV Make?

  • How Much Are Qiagen NV's Sales Annually?
    QGEN Revenues are $2B
  • How Much Profit Does Qiagen NV's Make A Year?
    QGEN net income is $341.3M

Is Qiagen NV Growing As A Company?

  • What Is Qiagen NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Qiagen NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Qiagen NV Stock Price Performance

  • Did Qiagen NV Stock Go Up Last Month?
    Qiagen NV share price went down by -2.9% last month
  • Did QGEN's Share Price Rise Over The Last Year?
    QGEN share price rose by 10.25% over the past 1 year

What Is Qiagen NV 52-Week High & Low?

  • What Is Qiagen NV’s 52-Week High Share Price?
    Qiagen NV has traded as high as $47.44 over the past 52 weeks
  • What Is Qiagen NV’s 52-Week Low Share Price?
    Qiagen NV has traded as low as $35.81 over the past 52 weeks

Qiagen NV Price To Free Cash Flow

Is It Risky To Buy Qiagen NV?

  • How Much Debt Does Qiagen NV Have?
    Total long term debt quarterly is $1.4B
  • How Much Cash Does Qiagen NV Have?
    Cash and short term investments quarterly total is $890.2M
  • What Is Qiagen NV’s Book Value Per Share?
    Book value per share is 15.32

Is Qiagen NV Cash Flow Positive?

  • What Is QGEN Cash Flow From Operations?
    Cash flow from operations (TTM) is $575.7M
  • What Is Qiagen NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$828M
  • What Is Qiagen NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $178.5M

Qiagen NV Return On Invested Capital

  • Is Management Doing A Good Job?
    QGEN return on invested capital is 1.4%
  • What Is Qiagen NV Return On Assets?
    ROA measures how assets are converting to revenues and is 1.22%
  • What Is QGEN Return On Equity?
    ROE is a measure of profitability and is 2.01%

Qiagen NV Earnings Date & Stock Price

  • What Is Qiagen NV's Stock Price Today?
    A single share of QGEN can be purchased today for 45.59
  • What Is Qiagen NV’s Stock Symbol?
    Qiagen NV trades on the nyse under the ticker symbol: QGEN
  • When Is Qiagen NV’s Next Earnings Date?
    The next quarterly earnings date for Qiagen NV is scheduled on October 30, 2024
  • When Is QGEN's next ex-dividend date?
    Qiagen NV's next ex-dividend date is January 30, 2024
  • How To Buy Qiagen NV Stock?
    You can buy Qiagen NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Qiagen NV Competitors

  • Who Are Qiagen NV's Competitors?
    Below is a list of companies who compete with Qiagen NV or are related in some way:
    • argenx SE (ARGX)
    • LENZ Therapeutics Inc (LENZ)
    • Oruka Therapeutics Inc (ORKA)
    • uniQure NV (QURE)
    • Thermo Fisher Scientific Inc (TMO)

Qiagen NV Dividend Yield

  • What Is QGEN Dividend Yield?
    Qiagen NV’s dividend yield currently is 0%
  • What Is Qiagen NV’s Payout Ratio?
    Qiagen NV’s payout ratio is 0%
  • When Did Qiagen NV Last Pay A Dividend?
    The latest dividend pay date is September 20, 2024
  • What Is Qiagen NV’s Dividend Per Share?
    Qiagen NV pays a dividend of $0.00 per share

Qiagen NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.02%
Revenue: 0.3% 0.35%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 50.72
Upside from Last Price: 11.25%

Major Shareholders

  • How many QGEN shares are owned by institutional investors?
    269.1M QGEN shares are owned by institutional investors
  • How many QGEN shares are owned by insiders?
    0 QGEN shares are owned by insiders